InsiderTrades

Form 4 for INSM INSMED Inc

Accepted 2024-01-11 00:00:00 ET · period of report 2024-01-09 · accession 0001628280-24-001164 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-01-11 2024-01-09 INSM Schaeffer Orlov S Nicole Chief People Strategy Off S - Sale+OE $28.85 -3,668 105.1K -3% -$105.8K
D 2024-01-11 2024-01-09 INSM Schaeffer Orlov S Nicole Chief People Strategy Off M - OptEx $20.49 +503 105.7K +0.5% +$10.3K
D 2024-01-11 2024-01-09 INSM Schaeffer Orlov S Nicole Chief People Strategy Off M - OptEx $0.00 -503 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-01-09 S D 3,165 $28.74 101,984 D — — (F3) This is the weighted average sales price representing 3,165 shares sold at prices ranging from $28.72 to $28.74 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
2 Common Common Stock 2024-01-09 S D 503 $29.56 105,149 D — —
3 Common Common Stock 2024-01-09 M A 503 $20.49 105,652 D — —
4 Derivative Stock Option (right to buy) 2024-01-09 M D 503 $0.00 0 D $20.49 · — to 2024-01-10 503 Common Stock (F4) Stock options granted under the Company's 2013 Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.